Articles

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis

Department of Hematology/HCT, City of Hope National Medical Center, Duarte
Department of Pathology, City of Hope, Duarte
Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee
CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee,
Department of Pathology, City of Hope, Duarte
Department of Pathology, City of Hope, Duarte
Beckman Research Institute, City of Hope, Duarte
Divisions of Hematology/Oncology and Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee
Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh
Department of Hematology, Inselspital, Bern University Hospital, University of Bern
Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami
The Ottawa Hospital Transplant and Cellular Therapy Program, Ottawa, ON
Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble
Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte
Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston
Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston
Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesús, Madrid
Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville
University of Texas Health Science Center at San Antonio, San Antonio
Divsion of Cancer Epidemiology and Genetics, NIH-NCI Clinical Genetics Branch, Rockville
Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City
Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London
Department of Medical Oncology, Division of Hematological Malignancies, Thomas Jefferson University, Philadelphia
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte
Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland
Department of Internal Medicine, Mayo Clinic, Rochester, MN; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi
Markey Cancer Center, University of Kentucky, Lexington
University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland
Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester
Markey Cancer Center, University of Kentucky, Lexington
Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville
Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago
Department of Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa
Blood and Marrow Transplant Program, Huntsman Cancer Institute, University of Utah, Salt Lake City
Novant Health Cancer Institute; Charlotte
Department of Hematology and Oncology, Dokkyo Medical University, Tochigi
Mayo Clinic, Rochester
The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta
Department of Hematology/Oncology, Isala Clinic, Zwolle
Division of Medical Oncology, Washington University School of Medicine, St. Louis
Cleveland Clinic, Cleveland
Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston
Fred Hutchinson Cancer Research Center, Seattle
CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee
Department of Hematology/HCT, City of Hope National Medical Center, Duarte
Haematologica Early view Apr 21, 2022 https://doi.org/10.3324/haematol.2021.280203